Ou JN et al. |
Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. |
2007 |
Biochem. Pharmacol. |
pmid:17276411
|
Liu X et al. |
Nuclear factor Y regulation and promoter transactivation of human ribonucleotide reductase subunit M2 gene in a Gemcitabine resistant KB clone. |
2004 |
Biochem. Pharmacol. |
pmid:15041467
|
McBain JA et al. |
Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. |
1997 |
Biochem. Pharmacol. |
pmid:9214697
|
Ding BC et al. |
Association of deletions and translocation of the reduced folate carrier gene with profound loss of gene expression in methotrexate-resistant K562 human erythroleukemia cells. |
2001 |
Biochem. Pharmacol. |
pmid:11266651
|
Mikkelsen IM et al. |
Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif. |
2002 |
Biochem. Pharmacol. |
pmid:12123752
|
Xu L et al. |
Effect of the histone deacetylase inhibitor trichostatin A on the responsiveness of rat hepatocytes to dioxin. |
1997 |
Biochem. Pharmacol. |
pmid:9174108
|
Kohge T et al. |
Promotion of antigen-specific antibody production in murine B cells by a moderate increase in histone acetylation. |
1998 |
Biochem. Pharmacol. |
pmid:9825735
|
Jalonen U et al. |
Inhibition of tristetraprolin expression by dexamethasone in activated macrophages. |
2005 |
Biochem. Pharmacol. |
pmid:15710351
|
Sun C and Zhou J |
Trichostatin A improves insulin stimulated glucose utilization and insulin signaling transduction through the repression of HDAC2. |
2008 |
Biochem. Pharmacol. |
pmid:18495085
|
Brieger A et al. |
In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors. |
2004 |
Biochem. Pharmacol. |
pmid:15183120
|
Place RF et al. |
HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. |
2005 |
Biochem. Pharmacol. |
pmid:15950952
|
Wagner S and Roemer K |
Retinoblastoma protein is required for efficient colorectal carcinoma cell apoptosis by histone deacetylase inhibitors in the absence of p21Waf. |
2005 |
Biochem. Pharmacol. |
pmid:15763542
|
Kang J et al. |
Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. |
2005 |
Biochem. Pharmacol. |
pmid:15794941
|
Vanhaecke T et al. |
Effect of the histone deacetylase inhibitor trichostatin A on spontaneous apoptosis in various types of adult rat hepatocyte cultures. |
2004 |
Biochem. Pharmacol. |
pmid:15276083
|
Vandergeeten C et al. |
HIV-1 protease inhibitors do not interfere with provirus transcription and host cell apoptosis induced by combined treatment TNF-alpha + TSA. |
2007 |
Biochem. Pharmacol. |
pmid:17386923
|
Emmans VC et al. |
Regulation of cellular processes by PPARgamma ligands in neuroblastoma cells is modulated by the level of retinoblastoma protein expression. |
2004 |
Biochem. Soc. Trans. |
pmid:15494029
|
Kagoshima M et al. |
Glucocorticoid suppression of nuclear factor-kappa B: a role for histone modifications. |
2003 |
Biochem. Soc. Trans. |
pmid:12546654
|
Dowling DP et al. |
Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors. |
2008 |
Biochemistry |
pmid:19053282
|
Im H et al. |
Histone deacetylase-dependent establishment and maintenance of broad low-level histone acetylation within a tissue-specific chromatin domain. |
2002 |
Biochemistry |
pmid:12484752
|
Singh RK et al. |
Kinetic and thermodynamic rationale for suberoylanilide hydroxamic acid being a preferential human histone deacetylase 8 inhibitor as compared to the structurally similar ligand, trichostatin a. |
2013 |
Biochemistry |
pmid:24079912
|